2017
DOI: 10.1007/s40620-017-0436-4
|View full text |Cite
|
Sign up to set email alerts
|

Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
(6 reference statements)
1
1
0
Order By: Relevance
“…There is increasing awareness that BMD in kidney dialysis patients is a condition not just simply limited to biochemical abnormalities [27]. We report that lower BMD, evaluated by DXA, at the femoral neck but not at the lumbar spine were associated with greater aPWV, reinforcing the hypothesis of a link between bone disease and vascular disease in dialysis patients.…”
Section: Discussionsupporting
confidence: 67%
“…There is increasing awareness that BMD in kidney dialysis patients is a condition not just simply limited to biochemical abnormalities [27]. We report that lower BMD, evaluated by DXA, at the femoral neck but not at the lumbar spine were associated with greater aPWV, reinforcing the hypothesis of a link between bone disease and vascular disease in dialysis patients.…”
Section: Discussionsupporting
confidence: 67%
“…These effects on mineral homeostasis cause bone disorders. Recently, an increasing number of biologic and epidemiologic evidence has indicated that the two conditions share common pathophysiologic factors, and the bone also plays an active role in CKD-MBD [2]. Bone-kidney interactions via bone-derived substances such as fibroblast growth factor-23 (FGF-23), sclerostin, or osteocalcin may be implicated in CKD-MBD [3].…”
Section: Introductionmentioning
confidence: 99%